K. de Bruin

1.4k total citations
9 papers, 552 citations indexed

About

K. de Bruin is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology. According to data from OpenAlex, K. de Bruin has authored 9 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in K. de Bruin's work include Radiopharmaceutical Chemistry and Applications (2 papers), Medical Imaging Techniques and Applications (2 papers) and Receptor Mechanisms and Signaling (2 papers). K. de Bruin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (2 papers), Medical Imaging Techniques and Applications (2 papers) and Receptor Mechanisms and Signaling (2 papers). K. de Bruin collaborates with scholars based in Netherlands and United States. K. de Bruin's co-authors include Jan Booij, Eric A. van Royen, A.G.M. Janssen, Ellinor Busemann Sokole, Tom van der Poll, Luisa Camoglio, M B Affrime, J W ten Cate, David L. Cutler and Johannes D. Speelman and has published in prestigious journals such as The Lancet, The Journal of Immunology and International Journal of Obesity.

In The Last Decade

K. de Bruin

9 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. de Bruin Netherlands 7 124 120 113 95 61 9 552
Takao Enomoto Japan 16 30 0.2× 283 2.4× 171 1.5× 60 0.6× 55 0.9× 59 832
Terri Haddix United States 11 29 0.2× 87 0.7× 64 0.6× 62 0.7× 192 3.1× 18 709
Declan McGuone United States 15 72 0.6× 160 1.3× 75 0.7× 42 0.4× 210 3.4× 49 732
M. Bogdanow Germany 10 33 0.3× 55 0.5× 73 0.6× 116 1.2× 152 2.5× 16 560
Makoto Kanai Japan 13 72 0.6× 75 0.6× 90 0.8× 48 0.5× 137 2.2× 33 733
Stephen Keddie United Kingdom 16 36 0.3× 327 2.7× 144 1.3× 25 0.3× 90 1.5× 30 537
Ross J. Lennen United Kingdom 13 79 0.6× 30 0.3× 67 0.6× 68 0.7× 58 1.0× 20 466
Z. Sfaello Argentina 8 51 0.4× 72 0.6× 34 0.3× 32 0.3× 129 2.1× 16 399
F. Hanefeld Germany 11 37 0.3× 141 1.2× 34 0.3× 72 0.8× 149 2.4× 22 547
Mariana Postal Brazil 16 126 1.0× 91 0.8× 17 0.2× 384 4.0× 152 2.5× 34 928

Countries citing papers authored by K. de Bruin

Since Specialization
Citations

This map shows the geographic impact of K. de Bruin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. de Bruin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. de Bruin more than expected).

Fields of papers citing papers by K. de Bruin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. de Bruin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. de Bruin. The network helps show where K. de Bruin may publish in the future.

Co-authorship network of co-authors of K. de Bruin

This figure shows the co-authorship network connecting the top 25 collaborators of K. de Bruin. A scholar is included among the top collaborators of K. de Bruin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. de Bruin. K. de Bruin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Giessen, Elsmarieke van de, Susanne E. la Fleur, Leslie Eggels, et al.. (2012). High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. International Journal of Obesity. 37(5). 754–757. 56 indexed citations
2.
Knol, Remco J.J., K. de Bruin, Berthe L.F. van Eck‐Smit, & Jan Booij. (2007). No significant effects of single intravenous, single oral and subchronic oral administration of acetylcholinesterase inhibitors on striatal [123I]FP-CIT binding in rats. European Journal of Nuclear Medicine and Molecular Imaging. 35(3). 598–604. 4 indexed citations
3.
Habraken, Jan B. A., K. de Bruin, Mohamed Shehata, et al.. (2001). Evaluation of high-resolution pinhole SPECT using a small rotating animal.. PubMed. 42(12). 1863–9. 92 indexed citations
4.
Reneman, Liesbeth, Jules Lavalaye, Remco J.J. Knol, et al.. (2001). Dopamine transporter imaging as an in vivo marker of dopaminergic neurons. Drugs of the Future. 26(3). 271–271. 1 indexed citations
5.
Booij, Jan, et al.. (1999). One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.. PubMed. 40(5). 753–61. 97 indexed citations
6.
Booij, Jan, Ellinor Busemann Sokole, Michael G. Stabin, et al.. (1998). Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.. PubMed. 25(1). 24–30. 62 indexed citations
7.
Pajkrt, Dasja, Luisa Camoglio, K. de Bruin, et al.. (1997). Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. The Journal of Immunology. 158(8). 3971–3977. 159 indexed citations
8.
Rosendaal, F.R., K. de Bruin, Jan P. Vandenbroucke, et al.. (1991). Mortality in hereditary antithrombin-III deficiency—1830 to 1989. The Lancet. 337(8736). 260–262. 54 indexed citations
9.
Verhoeff, N. P. L. G., Matthijs G.P. Feenstra, Gerard J. Boer, et al.. (1991). In vitro and in vivo D2-dopamine receptor binding with [123I]S(−)iodobenzamide ([123I]IBZM) in rat and human brain. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(8). 837–846. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026